Skip to main content

Table 1 Patients’ characteristics (n = 33)

From: Safety and efficacy of CT-guided radioactive iodine-125 seed implantation as a salvage treatment for recurrent head and neck cancer after two or more courses of radiotherapy

 

No. of patients

Percentage (%)

Median age (years)

53(32–72)

Gender

  

Male

22

66.7

Female

11

33.3

Primary tumor position

  

Nasopharynx

12

36.4

Hypopharynx

5

15.2

Paranasal sinus

5

15.2

Oral cavity

3

9.1

Larynx

3

9.1

Neck

3

9.1

Cervical lymph node metastases

2

6.1

Tumor pathology

  

SCC

25

75.8

Other

8

24.2

Implantation site

  

Primary tumor

22

66.7

Lymph nodes

11

33.3

Previous surgery

23

69.7

Previous chemotherapy

20

60.6

Courses of previous radiotherapy

  

Two

29

87.9

Three

4

12.1

Cumulative dose of the previous radiotherapy (Gy)

50–100

11

40.7

> 100

16

59.3

Median dose

110(60–160)

 

Median time from radiotherapy to seed implantation (months)

12.5(1.3–446)

  1. Abbreviations: SCC: Squamous cell carcinoma